A new era began April 10 with disappearance of China FDA and kickoff of State Administration for Market Regulation (SMAR), the so-called 'One-Stop' regulatory agency. Will the CFDA's innovation-encouraging policies continue? How will the new agency balance innovation and enforcement? Pink Sheet offers preliminary answers to these key questions and decode the new SMAR from five important aspects.
One month after a massive re-organization announcement, the curtain falls on the China FDA, China's food and drug regulatory agency. On April 10, a new agency, the State Administration for Market Regulation (SAMR) began.
SMAR was born out of the government's ambitious goal to consolidate regulatory powers split among several agencies, eliminate loops caused...